Evidence map›Paper›PMID 19722834›Full record

ReviewFuture microbiology2009

Activity of trypanosome lytic factor: a novel component of innate immunity.

Russell Thomson, Marie Samanovic, Jayne Raper

Open access · greenAbstract readReview
In one paragraph

Review in Future microbiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 33 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Germline-targeted baboon apolipoprotein L-1 protects mice against African trypanosomes.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Wildlife surveys detectCurrent research in parasitology & vector-borne diseases · 2026
    Article
  5. Article
  6. Review
  7. Review
  8. Revisiting the Mechanisms of Immune Evasion Employed by Human Parasites.Frontiers in cellular and infection microbiology · 2021
    Review
  9. Article
  10. Review
  11. Review
  12. Distinct Proteomic Signatures in 16 HDL (High-Density Lipoprotein) Subspecies.Arteriosclerosis, thrombosis, and vascular biology · 2018
    Article
  13. Review
  14. Article
  15. Wild chimpanzees are infected by Trypanosoma brucei.International journal for parasitology. Parasites and wildlife · 2015
    Article
  16. Crosstalk between reverse cholesterol transport and innate immunity.Trends in endocrinology and metabolism: TEM · 2012
    Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Russell ThomsonMedical Parasitology, New York University Langone Medical Center, 341 East 25th Street, New York, NY 10010, USA. russell.thomson@nyumc.org
Marie Samanovic
Jayne Raper
NYU Langone Health · US

Funding

RECEPTORS FOR THE TRYPANOLYTIC FACTORS FROM HUMAN SERUMR01AI041233 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI RAPER, JAYNE · 2004 to 2008
$1.6M
NIAID NIH HHS R01 AI041233
6 · The paper itself

Abstract

Trypanosome lytic factors (TLFs) are high-density lipoproteins and components of primate innate immunity. TLFs are characterized by their ability to kill extracellular protozoon parasites of the genus Trypanosoma. Two subspecies of Trypanosoma brucei have evolved resistance to TLFs and can consequently infect humans, resulting in the disease African sleeping sickness. The unique protein components of TLFs are a hemoglobin-binding protein, haptoglobin-related protein and a pore-forming protein, apoL-I. The recent advances in our understanding of the roles that these proteins play in the mechanism of TLF-mediated lysis are highlighted in this article. In light of recent data, which demonstrate that TLFs can ameliorate infection by the intracellular pathogen Leishmania, we also discuss the broader function of TLFs as components of innate immunity.

Indexed as

Immunity, InnateAnimalsHumansLeishmaniaLipoproteins, HDLPrimatesTrypanosomaLipoproteins, HDLTLF1 protein, human

Identifiers

PMID19722834
PMCPMC2777647
OpenAlexW2019872072

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.